Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.

Neutraceutical food patent company

Equity Belgium 73 investors Tax Shelter applicable

Tax Shelter

Making industrial food cholesterol-friendly
Information Note Terms & Conditions
€1,000,000
Pre money valuation
33.3%
Equity offered
€94,100
Amount raised
€50,000
Committed by co-investors
64 days
Remaining
€50,000
Minimum target
188% funded

The capital increase in which Spreds Finance will participate with other investors fits into a broader financing of Neutraceutical food patent company (pending incorporation) planned to be between €150,000 and €500,000 (the “Capital Increase”).

The Notes shall only be issued if the following, cumulative, conditions precedent to the subscription of Spreds Finance to the capital increase of Neutraceutical food patent company (pending incorporation) listed below are fulfilled within 6 months of the Closing Date:
• The total amount of firm commitments of subscription to this Capital Increase reaches at least €150,000 and do not exceed €500,000.
• The pre money valuation of Neutraceutical food patent company (pending incorporation) does not exceed €1,000,000. • One or more investors invest a minimum of €50,000.
• Spreds Finance participates in the Capital Increase for an amount equal to the result of the subscription to the Notes of the Neutraceutical food patent company Compartment.
• Spreds Finance is granted equal rights in terms of transferability of the shares of Neutraceutical food patent company (pending incorporation) as those stipulated for the benefit of the other investors participating in the Capital Increase.

Furthermore, Spreds Finance is granted a tag along right with regard to one or more shareholders of Neutraceutical food patent company (pending incorporation) in the sense that, in case of transfer of shares of the company by the designated shareholder (including the sale, transfer, exchange, etc. of shares) Spreds Finance will be able to transfer its shares in Neutraceutical food patent company (pending incorporation) at the same time, in the same proportion and under the same conditions.

Spreds Finance checks if such conditions precedent are fulfilled at the latest 6 months after the Closing Date (“Effective Date”). In case one or several of these conditions is not fulfilled on the Effective Date, the Notes will not be issued and the Investors will be reimbursed their respective Subscription Amount no later than 15 business days from the Effective Date.

The amount for which Spreds Finance would participate in the Capital Increase will be supplemented by other investments in order to reach a total amount of between a minimum €150,000 and a maximum €500,000.

Neutraceutical food patent company (pending incorporation) guarantees that the minimum amount planned for the Capital Increase, which is €150,000, will enable it to survive for at least six months, even without having any turnover.

TAX SHELTER 45%

This business qualifies for the startup tax shelter. If you meet the conditions, 45% of your investment will be reducted from your personal income taxes. Read more…